TerrAscend Corp. (TSNDF) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

TerrAscend Corp. (TSNDF) Healthcare & Pipeline Overview

TerrAscend Corp. is a North American cannabis enterprise, vertically integrated across cultivation, production, and distribution of diverse cannabis products for medical and adult-use markets. Operating under multiple brands and retail banners like Apothecarium, it maintains a significant presence in the evolving U.S. and Canadian cannabis landscapes, navigating a dynamic regulatory environment.

What Is the Investment Thesis for TSNDF?

TerrAscend Corp. presents a thesis centered on its vertically integrated model and multi-state/country operational footprint within the expanding North American cannabis market. With a gross margin of 50.9%, the company demonstrates efficiency in its production and cultivation processes, despite a current profit margin of -31.2%, indicating significant investment in growth or operational costs. Key value drivers include the continued legalization and expansion of adult-use cannabis markets in the United States, which could unlock substantial new revenue streams. The company's diverse brand portfolio and established retail presence through banners like Apothecarium provide a foundation for market penetration and customer retention. Growth catalysts include strategic acquisitions to expand geographic reach, new product introductions in high-demand categories, and potential federal regulatory reforms in the U.S. that could reduce operational hurdles and improve access to traditional financing. However, the company's beta of 2.04 signifies higher volatility relative to the market, and its 'OTC Other' classification introduces risks related to liquidity and disclosure. Achieving sustained profitability remains a critical factor for long-term value creation.

Based on FMP financials and quantitative analysis

TSNDF Key Highlights

Market capitalization stands at $0.27 billion, reflecting its current valuation in the OTC market.

• Gross margin of 50.9% indicates strong cost control in production relative to revenue.
• Profit margin of -31.2% suggests ongoing investments or operational expenses outweighing current revenues.
• A Beta of 2.04 signifies higher volatility compared to the broader market, indicating greater sensitivity to market movements.
• The company does not currently pay a dividend, consistent with growth-focused enterprises in emerging industries.

Who Are TSNDF's Competitors?

TSNDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TSNDF's Key Strengths?

Established presence across multiple U.S. states and Canada, offering geographic diversification.

• Vertically integrated operations covering cultivation, production, and distribution.
• Diverse product line including vaporizables, concentrates, dried flower, tinctures, and edibles.
• Robust multi-brand strategy with recognized names like Kind Tree Cannabis and GAGE Cannabis.
• Direct retail access through owned dispensary banners such as Apothecarium.

What Are TSNDF's Weaknesses?

Current negative profit margin of -31.2% indicates challenges in achieving profitability.

• Operating in the 'OTC Other' tier, which carries inherent risks of lower liquidity and less stringent listing requirements.
• High beta of 2.04 suggests significant stock price volatility.
• Reliance on a fragmented and evolving regulatory environment, particularly in the U.S.
• Unknown disclosure status on the OTC market may limit investor access to comprehensive financial information.

What Could Drive TSNDF Stock Higher?

TSNDF catalyst: Potential federal cannabis rescheduling or legalization in the United States, which could significantly reduce operational hurdles and expand market access.

• Entry into new, highly populated U.S. state markets that legalize adult-use cannabis, driving substantial revenue growth.
• Successful launch of new, high-margin product lines or innovative cannabis formulations that capture evolving consumer preferences.
• Strategic acquisitions or partnerships that expand TerrAscend's geographic footprint or enhance its product portfolio and market share.
• Improvements in operational efficiency and supply chain optimization leading to enhanced gross and net profit margins.

What Are the Key Risks for TSNDF?

Financial-distress signal — its Altman Z-Score of -1.14 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-45.8%) — the business is not currently generating profit on shareholder capital.
• Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.
• Continued federal prohibition of cannabis in the U.S., hindering interstate commerce and access to traditional financial services.
• Intense competition within the fragmented North American cannabis market, potentially leading to pricing pressures and market share erosion.
• Inability to achieve sustained profitability, as indicated by the current negative profit margin, impacting long-term financial viability.
• Adverse changes in state-level cannabis regulations, including taxation, licensing, or product restrictions, affecting operations.
• Risks associated with trading on the 'OTC Other' market, including lower liquidity, reduced transparency, and potential for price volatility.

What Are the Growth Opportunities for TSNDF?

• **Expansion into New Legalized U.S. State Markets:** As more U.S. states move towards medical or adult-use cannabis legalization, TerrAscend has the opportunity to leverage its existing operational expertise and brand portfolio to enter these new markets. Each new state market represents a significant revenue opportunity, often with initial high growth rates. For example, a major state legalizing adult-use cannabis could represent a multi-billion dollar market within a few years, offering TerrAscend a chance to establish early market share through strategic licensing and facility development, potentially within a 3-5 year timeline.
• **Product Diversification and Innovation:** The cannabis market continually evolves with consumer preferences for new product formats and potency levels. TerrAscend's existing product line includes vaporizables, concentrates, edibles, and tinctures, but there is ongoing opportunity to introduce innovative products like new cannabinoid formulations, functional edibles, or advanced delivery systems. Developing and launching these novel products can capture new consumer segments and increase market share, capitalizing on an estimated global cannabis edibles market projected to reach over $20 billion by 2027, with continuous R&D efforts over the next 1-2 years.
• **Leveraging Brand Portfolio and Retail Footprint:** TerrAscend operates a diverse portfolio of brands such as Kind Tree Cannabis, GAGE Cannabis, and Cookies, alongside retail banners like Apothecarium. There is significant potential to further strengthen brand equity and cross-promote products across its retail network. Enhancing the in-store experience, expanding loyalty programs, and optimizing brand positioning can drive increased foot traffic and higher average transaction values. This strategy aims to solidify customer loyalty and market presence, with ongoing initiatives to refine marketing and retail operations.
• **Operational Efficiency and Vertical Integration Optimization:** As a vertically integrated company, TerrAscend controls various stages from cultivation to retail. Continuous optimization of its supply chain, cultivation techniques, and manufacturing processes can lead to significant cost reductions and improved gross margins. Implementing advanced agricultural technologies, streamlining distribution logistics, and optimizing retail inventory management can enhance profitability. Such efficiency gains are critical in a competitive market and represent an ongoing opportunity for margin expansion over the next 1-3 years.
• **Strategic Partnerships and Acquisitions:** The fragmented nature of the cannabis industry presents opportunities for strategic partnerships or targeted acquisitions. TerrAscend could acquire smaller, specialized brands to expand its product offerings or enter new geographic regions more rapidly. Collaborating with established consumer goods companies for distribution or product development could also unlock new channels and expertise. These strategic moves, evaluated on an ongoing basis, can accelerate market penetration and consolidate market share, potentially adding significant revenue streams and operational synergies within a 2-4 year horizon.

What Threats Does TSNDF Face?

• Intense competition from other multi-state operators and new market entrants.
• Ongoing regulatory uncertainty and potential changes that could impact operations or market access.
• Illicit market competition, which can undercut prices and erode market share.
• Economic downturns impacting consumer discretionary spending on cannabis products.
• Challenges in accessing traditional banking and capital markets due to federal cannabis prohibition.

What Are TSNDF's Competitive Advantages?

• **Vertically Integrated Operations:** Control over the entire supply chain from cultivation to retail allows for quality control, cost efficiencies, and consistent product availability.
• **Diverse Brand Portfolio:** A wide array of established brands (e.g., Kind Tree, GAGE, Wana, Cookies) caters to different consumer segments and preferences, fostering brand loyalty.
• **Multi-State/Country Presence:** Operations in multiple U.S. states and Canada provide geographic diversification and market penetration in a fragmented regulatory landscape.
• **Retail Dispensary Network:** Direct-to-consumer sales through owned dispensaries like Apothecarium offer control over the customer experience and direct feedback channels.
• **Regulatory Compliance Expertise:** Navigating complex and evolving cannabis regulations across different jurisdictions builds specialized knowledge and operational resilience.

What Does TSNDF Do?

TerrAscend Corp. operates as a vertically integrated cannabis enterprise, established in 2017 with its corporate headquarters in King Of Prussia, Pennsylvania. The company has strategically positioned itself within the burgeoning North American cannabis market, encompassing both Canada and the United States. Its core operations span the entire cannabis value chain, from the cultivation of raw cannabis to the production of a diverse array of finished goods, and ultimately, their distribution through both wholesale channels and its proprietary retail dispensary network. TerrAscend's extensive product portfolio is designed to cater to a broad spectrum of consumer preferences, featuring vaporizable products, concentrates, topicals, dried flower, tinctures, and various edible formulations. To effectively reach its target demographics, the company leverages a robust multi-brand strategy, marketing its offerings under recognized names such as Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, and Lemonnade. Beyond its wholesale activities, TerrAscend directly engages with consumers through its managed retail cannabis dispensaries. These dispensaries operate under several distinct banners, including Apothecarium, TerrAscend, Pinnacle Emporium, GAGE Cannabis, and State Flower, providing direct access to its product lines for both medical cannabis patients and recreational adult consumers. This integrated approach allows TerrAscend to control product quality, manage supply chain efficiencies, and build brand loyalty across its North American operational footprint, employing approximately 950 individuals.

What Products and Services Does TSNDF Offer?

• Cultivate cannabis plants for medical and recreational markets.
• Produce a diverse range of cannabis products including vaporizables, concentrates, dried flower, tinctures, and edibles.
• Distribute cannabis products through wholesale channels to other retailers.
• Operate a network of retail cannabis dispensaries under various brand names like Apothecarium and GAGE Cannabis.
• Market products under multiple proprietary brands such as Kind Tree Cannabis, Legend, and Wana.
• Serve both medical cannabis patients and adult recreational consumers in North America.
• Manage a vertically integrated supply chain from seed to sale across its operations.

How Does TSNDF Make Money?

• **Cultivation and Production:** Generates revenue from growing cannabis and manufacturing derivative products like concentrates, edibles, and vapes.
• **Wholesale Distribution:** Sells its branded cannabis products to other licensed dispensaries and retailers across its operational regions.
• **Retail Sales:** Operates its own chain of dispensaries (e.g., Apothecarium, GAGE Cannabis) to sell products directly to medical patients and adult-use consumers.
• **Brand Licensing:** Potentially generates revenue through licensing its established cannabis brands to other operators in new markets, though specific details are not provided.
• **Diversified Product Portfolio:** Monetizes a wide array of cannabis product types, catering to various consumer preferences and price points.

What Industry Does TSNDF Operate In?

TerrAscend Corp. operates within the dynamic and rapidly evolving North American cannabis industry, categorized under Drug Manufacturers - Specialty & Generic within the Healthcare sector. This industry is characterized by significant regulatory fragmentation, with cannabis remaining federally illegal in the U.S. while individual states and Canada have legalized it for medical and/or recreational use. TerrAscend's vertically integrated model positions it to control quality and supply chain across cultivation, production, and retail. The competitive landscape includes numerous multi-state operators (MSOs), smaller craft cultivators, and pharmaceutical companies exploring cannabis-derived medicines. Market trends indicate a strong consumer shift towards regulated products and increasing demand for diverse product formats. TerrAscend aims to capture market share through its broad brand portfolio and established retail footprint, navigating the challenges of market entry and operational scaling in a highly regulated environment.

Who Are TSNDF's Key Customers?

• Medical cannabis patients seeking therapeutic benefits from cannabis products.
• Adult recreational consumers purchasing cannabis for leisure and wellness.
• Licensed third-party cannabis dispensaries and retailers who stock TerrAscend's branded products.
• Wholesale distributors within legal cannabis markets.
• Consumers across various demographics interested in specific cannabis product formats like edibles or concentrates.

Wall Street analysts project TerrAscend Corp. revenue of about $265.2M for fiscal 2026, with EPS near $-0.06.

Quarterly Financial Performance: TerrAscend Corp.

Revenue for TerrAscend Corp. came in at $65.4M during Q2 2026. The company recorded a net loss of $8.9M, with diluted EPS of $-0.03. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, TSNDF averaged $-0.03 in diluted EPS.

TSNDF Valuation & Market Position

With a $227M market cap, TerrAscend Corp. sits in the micro-cap segment of the market. Relative to its peer group, TSNDF's quantitative score of 49/100 is below the peer average of 65/100.

Return on equity for TerrAscend Corp. stands at -45.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 10.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.83 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -22.8%, the inverse of the P/E and a quick read on earnings relative to price.

TerrAscend Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.14 places it in the distress zone, a signal of elevated financial risk.

TerrAscend Corp. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 72.9% below estimates on average.

Company Profile

TerrAscend Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Mississauga, CA. The company is led by CEO Ziad Ghanem. TSNDF has traded publicly since 2017.

TSNDF Financials

TSNDF Latest News

No recent news available for TSNDF.

TSNDF Analyst Consensus

TSNDF MoonshotScore

What Investors Ask About TerrAscend Corp. (TSNDF) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources